Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO sub(4)

Background: Concerns have been raised about a possible excess risk of lymphomas in HIV-infected patients exposed to interleukin 2 (IL-2) therapy. Here we compared the risks of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) in IL-2-treated and IL-2-untreated HIV-infected patients. Methods: Pati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2009-02, Vol.50 (2), p.206-214
Hauptverfasser:	Fontas, E, Kousignian, I, Pradier, C, Duvivier, C, Poizot-Martin, I, Durier, C, Jarrousse, B, Weiss, L, Levy, Y, Costagliola, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome Age CD4 antigen Hodgkin's disease Hospitals Human immunodeficiency virus Interleukin 2 Regression analysis RNA Sex
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!